Fig. 2From: Platelet-rich plasma versus lidocaine as tenotomy adjuvants in people with elbow epicondylopathy: a randomized controlled trialPercentage of patients with an improvement exceeding 25% reduction in DASH-E (a) and in VAS-P (b) over 1-year follow-up, after adjusting data for baseline vascularization. DASH-E, Spanish version of the Disabilities of the Arm, Shoulder and Hand questionnaires; VAS-P, visual analogue scale for pain; m, monthBack to article page